Vivo Bio Tech Balance Sheet Health
Financial Health criteria checks 3/6
Vivo Bio Tech has a total shareholder equity of ₹598.0M and total debt of ₹578.8M, which brings its debt-to-equity ratio to 96.8%. Its total assets and total liabilities are ₹1.3B and ₹681.2M respectively. Vivo Bio Tech's EBIT is ₹171.2M making its interest coverage ratio 2.2. It has cash and short-term investments of ₹13.7M.
Key information
96.8%
Debt to equity ratio
₹578.83m
Debt
| Interest coverage ratio | 2.2x |
| Cash | ₹13.70m |
| Equity | ₹597.99m |
| Total liabilities | ₹681.22m |
| Total assets | ₹1.28b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 511509's short term assets (₹420.5M) exceed its short term liabilities (₹273.7M).
Long Term Liabilities: 511509's short term assets (₹420.5M) exceed its long term liabilities (₹407.5M).
Debt to Equity History and Analysis
Debt Level: 511509's net debt to equity ratio (94.5%) is considered high.
Reducing Debt: 511509's debt to equity ratio has increased from 72.5% to 96.8% over the past 5 years.
Debt Coverage: 511509's debt is well covered by operating cash flow (22.7%).
Interest Coverage: 511509's interest payments on its debt are not well covered by EBIT (2.2x coverage).